Cholesterol impact represents the primary concern, with HDL cholesterol often decreasing while LDL may increase
Strategies for Staying Motivated Instead of fixating on the scale, focus on non-scale victories like increased energy, improved sleep, or looser-fitting clothes
Trial status (May 2026): Eli Lilly reported positive topline results from the Phase 3 TRIUMPH-1 obesity trial on May 21, 2026, with mean weight reduction of 28.3% at 80 weeks on the 12 mg arm [1][2]
A cardiovascular outcomes trial for Foundayo is ongoing, with results expected in the coming years
Helps You Make the Most of Each GLP-1 Injection When you visit TrimBody M.D., you dont just get a prescription
Mild tenderness at the injection or IV site is possible